Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × capivasertib × Genitourinary × Clear all

Phase

Status

Sponsor Class

INDUSTRY 4 OTHER 3 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 3 enzalutamide 3 Abiraterone Acetate 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 apalutamide 2 Testosterone 2 Docetaxel 2 Cholecalciferol 2 Celecoxib 2 sulforaphane 1 gallium 68 PSMA-11 1 copanlisib 1 capivasertib 1 avelumab 1 abiraterone 1 Yoga 1 Tablets 1 Simvastatin 1 Sildenafil Citrate 1 Radiosurgery 1 Pluvicto 1 Perioperative Care 1 Pentoxifylline 1 Magnetic Resonance Imaging 1 Leuprolide 1 Ketoconazole 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Gelatin 1 Fecal Microbiota Transplantation 1 Estramustine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05593497 2025-04-16

SNARE

VA Office of Research and Development

Phase 2 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡